Nov. 17, 2020—A study group of more than 600,000 patients with type 2 diabetes, identified from electronic medical records in the PCORnet national research network, could be valuable for assessing the safety of type 2 diabetes drugs.
Nov. 3, 2020—Diabetes drugs known as GLP-1 receptor agonists, such as exenatide (Byetta), are a promising and safe treatment for a rare form of obesity.
Oct. 5, 2020—Vanderbilt researchers have identified a signaling pathway that promotes kidney fibrosis in patients with diabetes — and that could be targeted with an existing approved medication.
Sep. 11, 2020—One in nine American adults has diabetes, and one in three has pre-diabetes. Prevention and early intervention can decrease the risk of complications down the road.
Aug. 19, 2020—Research by Vanderbilt history professor Arleen Tuchman on the cultural history of diabetes offers important lessons for other public health challenges, including COVID-19.
Jul. 9, 2020—Vanderbilt cell biologists are defining the factors that help beta cells in the pancreas stay healthy, secrete insulin and prevent diabetes initiation and progression.
Apr. 8, 2020—Variation in the levels of hormones called natriuretic peptides may contribute to racial differences in susceptibility to diabetes, suggesting that this hormone system may be a target for reducing risk of the disease.
Feb. 20, 2020—Post-transplantation diabetes mellitus (PTDM), a common complication of immunosuppressive drugs that are given to prevent transplant rejection, may be reversible and at least partially preventable, researchers at VUMC report.
Dec. 11, 2019—Shichun Bao, associate professor of medicine and the Diabetes Technology Program leader in the Division of Endocrinology at the Eskind Diabetes Clinic, shares information on the amazing technological advances in diabetes treatment and blood sugar management.
Dec. 4, 2019—The identification of a protein important for insulin synthesis may hold clues for understanding the pathogenesis of diabetes.
Sep. 25, 2019—An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.
Aug. 22, 2019—The purpose of this study is to measure a metabolite called α-aminoadipic acid (2-AAA) in blood. Different amounts of 2-AAA in the body may alter the risk of developing diabetes